News
A deal for Becton Dickinson’s biosciences and diagnostic solutions unit puts Waters Corp. in a greater position to compete ...
Lab equipment maker Waters Corp on Monday said it will buy a bioscience and diagnostics unit spun off from medtech provider ...
Waters said it reached a deal to buy the Biosciences & Diagnostic Solutions business of Becton Dickinson for around $17.5 ...
Life sciences firm Waters will take on $4 billion in debt, and issue 39.2% of its shares to Becton Dickinson shareholders.
3d
GlobalData on MSNBD Biosciences & Diagnostic Solutions and Waters to merge in $17.5bn dealThe transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of ...
Milford-based biotech company Waters Corp. will merge with Becton, Dickinson and Co.’s biosciences an diagnostic solutions ...
Becton, Dickinson and Company is an attractive firm that just made a good deal. Click here to find out why BDX stock is a Buy ...
Any one of the majors will be thrilled to snap some of these brands because there’s very little organic growth in the ...
Medical analysis equipment maker Waters is combining with a unit of Becton Dickinson in a complex spin-merge. At a discount ...
Becton, Dickinson's divestment enhances focus, reduces leverage, funds buybacks, and unlocks value. Read more about the M&A ...
3d
Zacks.com on MSNBD Partners With Waters to Build High-Volume Diagnostics LeaderBDX collaborates with Waters in a $17.5B deal to form a diagnostics powerhouse targeting $9B in revenues by 2030.
Three months earlier than an expected update on a deal, Becton, Dickinson and Co. reported its biosciences and diagnostic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results